Moderna (BSP:M1RN34) Change In Inventory : R$2,147 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Moderna Change In Inventory?

Moderna's change in inventory for the quarter that ended in Mar. 2024 was R$-463 Mil. It means Moderna's inventory increased by R$463 Mil from Dec. 2023 to Mar. 2024 .

Moderna's change in inventory for the fiscal year that ended in Dec. 2023 was R$3,660 Mil. It means Moderna's inventory declined by R$3,660 Mil from Dec. 2022 to Dec. 2023 .

Moderna's Total Inventories for the quarter that ended in Mar. 2024 was R$1,469 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Moderna's Days Inventory for the quarter that ended in Mar. 2024 was 234.66.

Inventory Turnover measures how fast the company turns over its inventory within a year. Moderna's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.39.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Moderna's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 1.48.

Moderna Change In Inventory Historical Data

The historical data trend for Moderna's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Change In Inventory Chart

Moderna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-241.80

-7,882.93

2,580.74

3,660.15

Moderna Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial															1,125.06	87.37	1,126.02	1,396.44	-463.12

Moderna Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$2,147 Mil.

Moderna (BSP:M1RN34) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Moderna's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	1229.4005	/	478.061	*	365 / 4
	=	234.66

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Moderna's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	478.061	/	1229.4005
	=	0.39

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Moderna's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	1229.4005	/	831.627
	=	1.48

Moderna Change In Inventory Related Terms

Thank you for viewing the detailed overview of Moderna's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Moderna (BSP:M1RN34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (BSP:M1RN34) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

MRNA:USA MRNA:Peru MRNA:Mexico 0QFd:UK 0A45:UK 0QF:Germany MRNA:Austria

Address

200 Technology Square, Cambridge, MA, USA, 02139

Website

https://www.modernatx.com

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna (BSP:M1RN34) Headlines

No Headlines